A patent judgment against Boston Scientific Corp. has jumped to $501 million after a judge tacked on an additional $69 million in interest.

U.S. District Judge John Ward ruled Thursday to expand the damages award — decided by a federal jury in Marshall, Texas — to cover interest on royalties dating to the medical device maker’s 2004 U.S. launch of drug-coated heart stents.